Tectora Launches With 55 Million Dollars
Schrödinger, New Enterprise Associates and RA Capital Management formed Tectora Therapeutics and closed a 55-million-dollar Series A financing. Schrödinger contributed two early-stage oral small-molecule programs, SDGR-4594 and SDGR-8139, for immune-mediated diseases and received an…
